Gregory M. Glenn, President, R&D at NOVAVAX INC (NVAX), sold 1,183 shares at $170.00 ($201K) on 2021-10-15, disclosed to the SEC on 2021-10-19.
Open-market sale of $201k NVAX by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVAX | SELL | 2021-12-09 | $1.6M | — | Filing → |
| NVAX | SELL | 2021-12-02 | $3.2M | — | Filing → |
| NVAX | SELL | 2021-11-30 | $719K | — | Filing → |